Toggle navigation
Home
Feed
Channels
Profile
Home
Feed
Channels
Profile
Medspoke's Talks
Medspoke
Medspoke
Urology (the "Gold Journal")
Published October 5, 2026
National Trends in Urology Fellowship Training and Subspecialization: A 10-Year Analysis of the A...
October 6, 2026
Medspoke
Medspoke
BJU International
Published October 5, 2026
00:00
--:--
Testosterone breakthrough and outcomes during intensified therapy in metastatic hormone-sensitive...
October 6, 2026
Share
Testosterone breakthrough and outcomes during intensified therapy in metastatic hormone-sensitive prostate cancer: the ARASENS and LATITUDE trials.
https://www.medspoke.co/channel_journal?id=689&tap_id=15110
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
Medspoke
Medspoke
Annals of Internal Medicine
Published October 6, 2026
In methicillin-susceptible S aureus bacteremia, cefazolin was noninferior to flucloxacillin or cl...
October 6, 2026
Why are you reporting this TALK?